Enovix Quarterly Income Statements Chart
Quarterly
|
Annual
Enovix Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-29 | 2025-03-30 | 2024-12-29 | 2024-09-29 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-10-01 | 2023-07-02 | 2023-04-02 | 2023-01-01 | 2022-10-02 | 2022-07-03 | 2022-04-03 | 2022-01-02 | 2021-10-03 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenue | 7,468,000 | 5,098,000 | 9,717,000 | 4,317,000 | 3,768,000 | 5,272,000 | 7,381,000 | 200,000 | 42,000 | 21,000 | 1,093,000 | 8,000 | 5,101,000 | |||
| yoy | 98.20% | -3.30% | 31.65% | 2058.50% | 8871.43% | 25004.76% | 575.30% | 2400.00% | -99.18% | |||||||
| qoq | 46.49% | -47.54% | 125.09% | 14.57% | -28.53% | -28.57% | 3590.50% | 376.19% | 100.00% | -98.08% | 13562.50% | -99.84% | ||||
| cost of revenue | 5,526,000 | 4,837,000 | 8,665,000 | 4,959,000 | 4,423,000 | 7,072,000 | 19,769,000 | 16,809,000 | 14,235,000 | 12,248,000 | 10,356,000 | 6,629,000 | 5,739,000 | 515,000 | -415,000 | 104,000 |
| gross profit | 1,942,000 | 261,000 | ||||||||||||||
| yoy | ||||||||||||||||
| qoq | 644.06% | |||||||||||||||
| gross margin % | 26.00% | 5.12% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |||
| operating expenses: | ||||||||||||||||
| research and development | 28,148,000 | 25,929,000 | 22,433,000 | 24,220,000 | 29,065,000 | 48,788,000 | 34,582,000 | 13,508,000 | 16,553,000 | 23,749,000 | 15,545,000 | 13,948,000 | 15,827,000 | 12,731,000 | 28,408,000 | 10,301,000 |
| selling, general and administrative | 17,527,000 | 16,892,000 | 13,135,000 | 20,744,000 | 20,884,000 | 19,548,000 | 17,807,000 | 17,245,000 | 16,688,000 | 27,274,000 | 15,425,000 | 13,110,000 | 11,566,000 | 11,869,000 | 25,939,000 | 8,791,000 |
| restructuring cost | 3,661,000 | 38,146,000 | 3,021,000 | |||||||||||||
| total operating expenses | 45,675,000 | 42,821,000 | 35,568,000 | 48,625,000 | 88,095,000 | 68,336,000 | 52,389,000 | 33,774,000 | 37,652,000 | 51,023,000 | 35,891,000 | 27,058,000 | 27,393,000 | 25,115,000 | 53,932,000 | 19,196,000 |
| income from operations | -43,733,000 | -42,560,000 | -34,516,000 | -49,267,000 | -88,750,000 | -70,136,000 | -64,777,000 | -50,383,000 | -51,845,000 | -63,250,000 | -45,154,000 | -33,679,000 | -28,031,000 | -25,115,000 | -53,932,000 | -19,196,000 |
| yoy | -50.72% | -39.32% | -46.72% | -2.22% | 71.18% | 10.89% | 43.46% | 49.60% | 84.96% | 151.84% | -16.28% | 75.45% | ||||
| qoq | 2.76% | 23.31% | -29.94% | -44.49% | 26.54% | 8.27% | 28.57% | -2.82% | -18.03% | 40.08% | 34.07% | 20.15% | 11.61% | -53.43% | 180.95% | |
| operating margin % | -585.61% | -834.84% | -355.21% | -1141.23% | -2355.36% | -1330.35% | -877.62% | -25191.50% | -123440.48% | -301190.48% | -4131.20% | -420987.50% | -549.52% | |||
| other income: | ||||||||||||||||
| change in fair value of common stock warrants | -5,885,000 | 15,796,000 | -5,115,000 | 29,899,000 | -33,660,000 | 21,120,000 | 1,035,000 | 31,320,000 | -14,340,000 | |||||||
| gain on bargain purchase of assets | 4,761,000 | |||||||||||||||
| interest income | 2,427,000 | 2,434,000 | 2,587,000 | 2,859,000 | 3,326,000 | 3,560,000 | 4,128,000 | 4,326,000 | 3,150,000 | 2,466,000 | ||||||
| interest expense | -1,705,000 | -1,716,000 | -1,719,000 | -1,718,000 | -1,691,000 | -1,659,000 | -1,629,000 | -1,557,000 | -1,270,000 | -80,000 | -52,000 | |||||
| other income | -992,000 | 2,353,000 | 2,463,000 | -2,217,000 | 242,000 | 466,000 | -433,000 | 109,000 | -1,000 | 21,000 | -2,398,000 | 1,826,000 | 496,000 | 22,000 | -67,000 | -50,000 |
| total other income | -1,394,000 | 18,867,000 | -1,784,000 | 28,823,000 | -31,783,000 | 23,487,000 | 4,106,000 | 34,198,000 | -12,461,000 | -10,353,000 | 33,973,000 | -48,334,000 | 26,896,000 | 67,822,000 | -45,634,000 | 8,358,000 |
| income before income tax benefit | -45,127,000 | -23,693,000 | -36,300,000 | -20,444,000 | -120,533,000 | -46,649,000 | ||||||||||
| income tax benefit | -861,000 | -162,000 | 1,152,000 | 2,194,000 | -4,586,000 | -152,000 | ||||||||||
| net income | -44,266,000 | -23,531,000 | -37,452,000 | -22,638,000 | -115,947,000 | -46,497,000 | -60,038,000 | -16,185,000 | -64,306,000 | -10,110,250 | -82,013,000 | -1,135,000 | 42,707,000 | -99,566,000 | -10,838,000 | |
| yoy | -61.82% | -49.39% | -37.62% | 39.87% | 80.31% | 493.83% | -80.27% | 5565.73% | -89.85% | 656.72% | ||||||
| qoq | 88.12% | -37.17% | 65.44% | -80.48% | 149.36% | -22.55% | 270.95% | -74.83% | -87.67% | 7125.81% | -102.66% | -142.89% | 818.68% | |||
| net income margin % | -592.74% | -461.57% | -385.43% | -524.39% | -3077.15% | -881.96% | -813.41% | -8092.50% | -153109.52% | 0% | -925.00% | -1025162.50% | -22.25% | |||
| net gain attributable to non-controlling interests | 262,000 | |||||||||||||||
| net income attributable to enovix | -44,528,000 | -23,510,000 | -37,465,000 | -22,536,000 | -115,872,000 | -46,368,000 | ||||||||||
| net income per share | -0.22 | -0.12 | -0.2 | -0.13 | -0.67 | -0.28 | -0.37 | -0.1 | -0.41 | -0.47 | -0.07 | -0.53 | -0.01 | 0.28 | -0.72 | -0.08 |
| weighted-average number of common shares outstanding, basic and diluted | 204,819,119 | 191,304,975 | 172,399,172 | 117,218,893 | ||||||||||||
| net income attributable to non-controlling interests | -21,000 | 13,000 | -102,000 | -75,000 | -129,000 | |||||||||||
| gross margin | 1,052,000 | -642,000 | -655,000 | -1,800,000 | -12,388,000 | -16,609,000 | -14,193,000 | -12,227,000 | -9,263,000 | -6,621,000 | -638,000 | |||||
| impairment of equipment | 4,411,000 | |||||||||||||||
| weighted-average number of common shares outstanding, basic | 175,038,107 | 176,680,578 | 168,144,918 | 159,065,697 | 159,829,716 | 157,151,386 | 155,626,977 | 152,918,287 | 153,332,007 | 152,521,389 | 151,648,439 | 133,492,216 | ||||
| weighted-average number of common shares outstanding, diluted | 175,038,107 | 176,872,382 | 168,144,918 | 159,575,555 | 161,371,417 | 157,151,386 | 155,626,977 | 154,149,367 | 153,332,007 | 152,521,389 | 153,338,462 | 135,052,128 | ||||
| change in fair value of convertible preferred stock warrants and common stock warrants | -12,840,000 | 31,140,000 | -50,160,000 | 26,400,000 | 67,800,000 | -49,385,000 | 8,460,000 | |||||||||
| net income and comprehensive income | -73,603,000 | |||||||||||||||
| issuance of convertible preferred stock warrants | -369,000 | |||||||||||||||
| change in fair value of convertible promissory notes | -605,500 |
We provide you with 20 years income statements for Enovix stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Enovix stock. Explore the full financial landscape of Enovix stock with our expertly curated income statements.
The information provided in this report about Enovix stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.